Physician profile
Eric Channing Swei
NPI 1104274224
$8,100.64
in general payments reported to CMS, 2019-2025
12 companies · $852 in 2025
The $852 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $133 · 2021: $99.95 · 2022: $1,658 · 2023: $1,235 · 2024: $3,978 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,926 · Food and Beverage: $2,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,926.37 |
| Food and Beverage | $2,137.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $3,934.36 | 2023-2024 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Boston Scientific Corporation | $2,983.90 | 2022-2025 | Resolution 360 Clip, Axios, Spyglass Discover |
| Abbvie INC. | $332.42 | 2019-2023 | Creon, Linzess |
| Micro-Tech Endoscopy USA, INC. | $229.01 | 2023 | Goldknife |
| Erbe USA INC | $106.62 | 2023 | Erbe Vio3, Erbe Jet, Erbe |
| Enterra Medical, INC. | $105.36 | 2024 | |
| Amgen INC. | $104.32 | 2025 | |
| Janssen Biotech, INC. | $99.95 | 2021 | |
| Steris Corporation | $78.90 | 2025 | |
| Olympus America INC. | $57.42 | 2019-2024 | Single Use Biliary Balloon Dilator, Endoclot Phs |
| Takeda Pharmaceuticals U.S.A., INC. | $47.66 | 2023 | Entyvio |
| Pentax of America, INC. | $20.72 | 2023 | C2 Cryoballoon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Swei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.